logo
  • 关于我们
  • 产品管线
  • 最新资讯
  • 加入瓴路
  • 联系我们
  • EN

最新资讯

Overland Therapeutics Launches with the Mission of Accelerating Global Development of First and Best-in-Class Cell Therapies

2024年5月24日

Overland Pharmaceuticals Announces Presentations at ASGCT Annual Meeting for Novel Cell Therapies for Oncology and Autoimmune Diseases

2024年5月9日

瓴路药业任命Xun Liu博士为首席技术官

2022年3月1日

瓴路药业任命张晓雷为首席执行官,并聘请行业领袖John Maraganore和Peter Ho担任战略顾问

2022年1月18日

瓴路药业任命罗锋(Roger Luo)博士为首席开发官

2021年8月2日

锐意进取,开拓创新:瓴路药业启航为亚洲及全球的生物制药建立纽带

2020年12月9日

Overland Therapeutics

隐私政策 使用条款

© Overland Therapeutics

沪公网安备31010602008318号 | 沪ICP备2022025163号-2

隐私保护同意管理

我们使用 Cookie 来优化网站功能并为您提供最佳体验。隐私政策

功能性 Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
分析性
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
偏好设置
{title} {title} {title}